AtriCure Analyst Price Targets

Wall Street analyst price targets and consensus rating for AtriCure (ATRC).

Price Target Range — 13 Quarters

Analyst Consensus — 11 Analysts

3S.Buy

7Buy

1Hold

Consensus RatingBuy# Analysts11Avg. Consensus PT$56Upside to Avg. PT-9.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 21, 2026	Citizens	Daniel Stauder	PT Raise	Market Outperform	$52→$68
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$55→$63
Oct 2, 2026	Freedom Capital Markets	Keith Hinton	Downgrade	Buy→Hold	$43→$57
Sep 2, 2026	Needham	Mike Matson	PT Raise	Buy	$45→$64
Aug 27, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$50→$60
Aug 24, 2026	BTIG	Marie Thibault	PT Raise	Buy	$45→$55
Jul 28, 2026	UBS	Priya Sachdeva	PT Cut	Buy	$55→$50
May 6, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$53→$55
Feb 18, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$64→$53
Feb 18, 2026	UBS	Danielle Antalffy	PT Cut	Buy	$60→$55
Feb 18, 2026	Citizens	Daniel Stauder	PT Cut	Market Outperform	$60→$52
Feb 18, 2026	Oppenheimer	Suraj Kalia	Downgrade	Outperform→Perform	—
Feb 18, 2026	BTIG	Marie Thibault	Maintained	Buy	$54
Feb 12, 2026	Needham	Mike Matson	Maintained	Buy	$45
Dec 16, 2025	JP Morgan	Lilia-Celine Lozada	PT Raise	Overweight	$42→$48
Oct 30, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$53→$64
Jul 30, 2025	Needham	Mike Matson	PT Raise	Buy	$44→$45
Apr 30, 2025	BTIG	Marie Thibault	PT Cut	Buy	$58→$52
Apr 30, 2025	UBS	Danielle Antalffy	PT Cut	Buy	$60→$58
Apr 30, 2025	JMP Securities	Daniel Stauder	Maintained	Market Outperform	$60

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

Citizens analyst Daniel Stauder maintains AtriCure (NASDAQ:ATRC) with a Market Outperform and raises the price target from $52 to $68.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on AtriCure, Raises Price Target to $63

BTIG analyst Ryan Zimmerman maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $55 to $63.

Benzinga Newsdesk

Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday

Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with ATRC downgraded to Hold.

Avi Kapoor

This AST SpaceMobile Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Analysts downgraded FHTX, BUSE, ASTS, ATRC and EQBK; targets fell for BUSE, ASTS and EQBK but rose for ATRC.

Avi Kapoor

PRO
Freedom Capital Markets Downgrades AtriCure to Hold, Raises Price Target to $57

Freedom Capital Markets analyst Keith Hinton downgrades AtriCure (NASDAQ:ATRC) from Buy to Hold and raises the price target from $43 to $57.

Benzinga Newsdesk

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Cantor Fitzgerald raised

Avi Kapoor

AtriCure Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

AtriCure Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

PRO
BTIG Maintains Buy on AtriCure, Raises Price Target to $63

Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday

This AST SpaceMobile Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

PRO
Freedom Capital Markets Downgrades AtriCure to Hold, Raises Price Target to $57

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

People Also Watch

People Also Watch

AtriCure Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

AtriCure Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

PROBTIG Maintains Buy on AtriCure, Raises Price Target to $63

Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday

This AST SpaceMobile Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

PROFreedom Capital Markets Downgrades AtriCure to Hold, Raises Price Target to $57

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

People Also Watch

People Also Watch

PRO
Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

PRO
BTIG Maintains Buy on AtriCure, Raises Price Target to $63

PRO
Freedom Capital Markets Downgrades AtriCure to Hold, Raises Price Target to $57